1.
Rhinitis and sinusitis
by Dykewicz, Mark S., MD
Journal of allergy and clinical immunology, 2010, Vol.125 (2), p.S103-S115
2.
Chronic rhinosinusitis: Epidemiology and medical management
by Hamilos, Daniel L., MD
Journal of allergy and clinical immunology, 2011, Vol.128 (4), p.693-707
3.
Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome
by Ramakrishnan, Vijay R., MD
Journal of allergy and clinical immunology, 2015, Vol.136 (2), p.334-342.e1
4.
Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Imm...
by Akdis, Cezmi A., MD
Journal of allergy and clinical immunology, 2013, Vol.131 (6), p.1479-1490
5.
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
by Shin, Hyun-Woo, MD, PhD
Journal of allergy and clinical immunology, 2015, Vol.135 (6), p.1476-1485.e7
6.
Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
by Bachert, Claus, MD, PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (6), p.1431-1440
7.
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois
by Tan, Bruce K., MD, MS
Journal of allergy and clinical immunology, 2016, Vol.139 (2), p.699-703.e7
8.
Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4
by Soyka, Michael B., MD
Journal of allergy and clinical immunology, 2012, Vol.130 (5), p.1087-1096.e10
9.
Rhinosinusitis: Establishing definitions for clinical research and patient care
by Meltzer, Eli O
Journal of allergy and clinical immunology, 2004, Vol.114 (6), p.155-212
10.
The role of interleukin-33 in chronic rhinosinusitis
by Kim, Dong-Kyu
Thorax, 2017-07, Vol.72 (7), p.635-645
11.
Microbiology of chronic rhinosinusitis
by Brook, I
European Journal of Clinical Microbiology and Infectious Diseases, 2016-04-16, Vol.35 (7), p.1059-1068
12.
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
by Pothoven, Kathryn L., MSc
Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.737-746.e4
13.
Pulmonary and sinus fungal diseases in non-immunocompromised patients
by Denning, David W
The Lancet infectious diseases, 2017-11, Vol.17 (11), p.e357-e366
14.
Rhinosinusitis Diagnosis and Management for the Clinician: A Synopsis of Recent Consensus Guidelines
by Meltzer, Eli O., MD
Mayo Clinic proceedings, 2011, Vol.86 (5), p.427-443
15.
Oral steroids and doxycycline: Two different approaches to treat nasal polyps
by Van Zele, Thibaut, MD, PhD
Journal of allergy and clinical immunology, 2010, Vol.125 (5), p.1069-1076.e4
16.
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease
by Buchheit, Kathleen M., MD
Journal of allergy and clinical immunology, 2015, Vol.137 (5), p.1566-1576.e5
17.
Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps
by Milara, Javier, PhD, PharmD
Journal of allergy and clinical immunology, 2014, Vol.135 (2), p.470-476
18.
Sinusitis in the common cold
by Puhakka, Tuomo
Journal of allergy and clinical immunology, 1998, Vol.102 (3), p.403-408
19.
Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
by Zhang, Nan, MD, PhD
Journal of allergy and clinical immunology, 2008, Vol.122 (5), p.961-968
20.
Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis
by Mulligan, Jennifer K., PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (2), p.342-349.e1
